1 / 20

Group A Streptococcal GAS Disease strep throat, necrotizing fasciitis, impetigo By: Dr. Awatif Alam

What is group A streptococcus (GAS)? . - Group A streptococcus is a bacterium often found in the throat and on the skin- People may carry group A streptococci in the throat or on the skin and have no symptoms of illness. - Most GAS infections are relatively mild illness

dai
Télécharger la présentation

Group A Streptococcal GAS Disease strep throat, necrotizing fasciitis, impetigo By: Dr. Awatif Alam

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Group A Streptococcal (GAS) Disease (strep throat, necrotizing fasciitis, impetigo) By: Dr. Awatif Alam

    2. What is group A streptococcus (GAS)? - Group A streptococcus is a bacterium often found in the throat and on the skin - People may carry group A streptococci in the throat or on the skin and have no symptoms of illness. - Most GAS infections are relatively mild illnesses such as "strep throat," or impetigo. - On rare occasions, these bacteria can cause other severe and even life-threatening diseases .

    3. How are group A streptococci spread? -These bacteria are spread through: * direct contact with mucus from the nose or throat of infected persons or * through contact with infected wounds or sores on the skin. -Ill persons, having strep throat or skin infections, are most likely to spread the infection. - Asymptomatic carriers are much less contagious. -Treating an infected person with an antibiotic for 24 hours or longer generally eliminates their ability to spread the bacteria. -It is not likely that household items like plates, cups, or toys spread these bacteria.

    4. What kind of illnesses are caused by group A streptococcal infection? Infection with GAS can result in a range of symptoms: 1.No illness. 2.Mild illness (strep throat or a skin infection such as impetigo). 3.Severe illness (necrotizing faciitis, streptococcal toxic shock syndrome).

    5. PROGNOSIS: Severe, sometimes life-threatening, GAS disease may occur when bacteria get into parts of the body where bacteria usually are not found, such as the blood, muscle, or the lungs. These infections are termed "invasive GAS disease. Two of the most severe, but least common, forms of invasive GAS disease are necrotizing fasciitis and Streptococcal Toxic Shock Syndrome.

    6. PROGNOSIS: - Necrotizing fasciitis (occasionally described by the media as "the flesh-eating bacteria") destroys muscles, fat, and skin tissue. Streptococcal toxic shock syndrome (STSS), causes blood pressure to drop rapidly and organs (e.g., kidney, liver, lungs) to fail. - About 20% of patients with necrotizing fasciitis and more than half with STSS die. - About 10%-15% of patients with other forms of invasive group A streptococcal disease die.

    7. How common is invasive group A streptococcal disease? -About 9,400 cases of invasive GAS disease occurred in the U.S.A in 1999. - Of these, about 300 were STSS and 600 were necrotizing fasciitis. -In contrast, there are several million cases of strep throat and impetigo each year.

    8. Why does invasive group A streptococcal disease occur? It occurs when the bacteria get past the defenses of the person who is infected. This may occur when a person has sores or other breaks in the skin that allow the bacteria to get into the tissue, or when the persons ability to fight off the infection is decreased because of chronic illness or an illness that affects the immune system. Also, some virulent strains of GAS are more likely to cause severe disease than others.

    9. Who is most at risk of getting invasive group A streptococcal disease? - Few people who come in contact with GAS will develop invasive GAS disease. - Most people will have a throat or skin infection, and some may have no symptoms at all. - Although healthy people can get invasive GAS disease, people with chronic illnesses like cancer, diabetes, and kidney dialysis, and those who use medications such as steroids have a higher risk.

    10. What are the early signs and symptoms of necrotizing fasciitis and streptococcal toxic shock syndrome? Early signs and symptoms of necrotizing fasciitis; - Fever - Severe pain and - Swelling - Redness at the wound site

    11. Early signs and symptoms of STSS; - Fever - Dizziness - Confusion - A flat red rash over large areas of the body

    12. How is invasive group A streptococcal disease treated? - GAS infections can be treated with many different antibiotics. - Early treatment may reduce the risk of death from invasive group A streptococcal disease. - However, even the best medical care does not prevent death in every case - For those with very severe illness, supportive care in an intensive care unit may be needed. - For persons with necrotizing fasciitis, surgery often is needed to remove damaged tissue

    13. What can be done to help prevent group A streptococcal infections? 1- Reduce the spread by: good hand washing, especially after coughing and sneezing and before preparing foods or eating. 2- If the test result shows strep throat, the person should: stay home from work, school, or day care until 24 hours after taking an antibiotic. 3- All wounds should be kept clean and watched for possible signs of infection such as: redness, swelling, drainage, and pain at the wound site. NOTE: - It is not necessary for all persons exposed to someone with an invasive group A strep infection to receive antibiotic therapy to prevent infection. - However, in certain circumstances, antibiotic therapy may be appropriate.

    14. Rheumatic Fever & RH. Heart Disease: -It is a febrile illness occurring as a delayed sequel of infections with GAS -This is evidenced by occurrence of antibodies to streptococcal antigens. -The disease can be prevented by antimicrobial therapy or prophylaxis of GAS. -The mechanism by which the hemolytic streptococci initiate rheumatic fever is still obscure. - The organisms exert their effect through some indirect process ( not by presence of GAS in the host tissues).

    15. -The symptoms of RF first become manifest after an interval of several days to several weeks following the acute streptococcal Infection ( when GAS may no longer be recoverable on culture of nose or throat occurrence). - A small % of persons subsequently develop rheumatic fever. - The infrequent occurrence of RF Is dependent upon host factors rather than on differences in the organism.

    16. Incidence & epidemiology: - Rheumatic fever is primarily a disease of childhood. - A peak incidence of age between 315 years - The disease is rare in infants. - Become less common with advancing age. - Predominance in childhood is directly related to the high incidence of GAS infection during childhood. - No available accurate figures on incidence due to difficulties in diagnosis, and being not reportable in many countries. - A wide range of 0.1 5 % is used.

    17. - The peak incidence of streptococcal disease is during late winter and early spring. - RF is more common among big families. - More among low SES groups. - Overcrowding, mal-housing, malnutrition. - Hereditary predisposition ( familial ).

    18. Mortality Rates / RHD : - Relatively high in developing countries. - Deaths from CVD among < 35 years of age is due to RHD. - About one third of all deaths from CVD.

    19. PREVENTION: A- In non- rheumatic subjects: - Prompt & intensive treatment of GAS infections , penicillin greatly reduces the risk of RF. B- Prevention of recurrences: - Depends on prevention of GAS infection - Every rheumatic patient should receive continuous prophylactic therapy for at least five years following last attack of disease. - Prophylaxis should be continued indefinitely in all patients with significant heart disease.

    20.

More Related